Contrast-enhanced ultrasound with sulphur-hexafluoride in diagnosis of early HCC in cirrhosis

Abstract

Contrast-enhanced ultrasound (CEUS) with pure blood stream contrast agents allow the study of blood supply of focal liver lesions and especially of hepatocellular carcinoma (HCC) in cirrhosis. Its sensitivity and specificity in diagnosis of small tumors is very high. This review summarizes the recent results on CEUS with SonoVue, which is one of the second generation contrast agents, in the diagnosis of early HCC in cirrhosis emphasizing its increasing role in routine clinical practice.

Keywords

Hepatocellular carcinoma / contrast-enhanced ultrasound / cirrhosis / early hepatocellular carcinoma

References

[1] Van Malenstein H,Verslype C.Molecular classification of hepatocellular carcinoma anno 2011..Eur J Cancer2011;47:1789-97

[2] El-Serag HB,Petersen NJ.The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update..Ann Intern Med2003;139:817-23

[3] McGlynn KA.Epidemiology and natural history of hepatocellular carcinoma..Best Pract Res Clin Gastroenterol2005;19:3-23

[4] Trevisani F,Wands JR.Recent advances in the natural history of hepatocellular carcinoma..Carcinogenesis2008;29:1299-305

[5] Ho DW,Chan LK.Molecular pathogenesis of hepatocellular carcinoma..Liver Cancer2016;5:290-302 PMCID:PMC5075835

[6] Poon RT,Lo CM,Wong J.Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation..Ann Surg2002;235:373-82 PMCID:PMC1422443

[7] Arii S,Futagawa S,Kobayashi Kojiro M.Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan..Hepatology2000;32:1224-9

[8] Omata M,Kokudo N,Lee JM.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update..Hepatol Int2017;11:317-70 PMCID:PMC5491694

[9] Korean Liver Cancer Study Group (KLCSG) and National Cancer Center, Korea (NCC)2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma..Gut Liver2015;9:267-317 PMCID:PMC4413964

[10] Julie K. Heimbach,Richard S. Finn.AASLD guidelines for the treatment of hepatocellular carcinoma..Hepatology2018;67:358-80

[11] European Association for the Study of the LiverEASL clinical practice guidelines: management of hepatocellular carcinoma..J Hepatol2018;69:182-236

[12] Italian Multi-Society reccomandations for the integrated management of Hepatocelluar Carcinoma. Published on line dec 22, 2106. Available from: https://www.sirm.org/wp-content/uploads/2019/03/HCC.pdf. [Last accessed on 24 May 2019]

[13] Claudon M,Choi BI,Kudo M.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS..Ultrasound Med Biol2013;39:187-210

[14] Choi JY,Sirlin CB.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects..Radiology2014;272:635-54 PMCID:PMC4263631

[15] International Consensus Group for Hepatocellular NeoplasiaPathologic diagnosis of early hepatocellular carcinoma: a report of theinternational consensus group for hepatocellular neoplasia..Hepatology2009;49:658-64

[16] Quaia E,Bertolotto M,Garioni L.Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence..Radiology2004;232:420-30

[17] Salvatore V,Negrini G,Galassi M.Imaging diagnosis of hepatocellular carcinoma: recent advances of contrast-enhanced ultrasonography with SonoVue®..Liver Cancer2016;5:55-66 PMCID:PMC5704684

[18] Giorgio A,Tarantino L,Scala V.Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance..AJR Am J Roentgenol2004;183:1319-26

[19] Giorgio A,Coppola C,Esposito V.Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging..Anticancer Res2007;27:4263-9

[20] Quaia E,Grisi G,Cova MA.The role of CEUS in the characterization of hepatocellular nodules detected during the US surveillance program--current practices in Europe..Ultraschall Med.2012;33 Suppl 1:S48-56

[21] Dong Y,Cao J,Wang WP.Characterization of focal liver lesions indistinctive on b mode ultrasound: benefits of contrast-enhanced ultrasound..Biomed Res Int2017;2017:8970156

[22] Dong Y,Mao F.Contrast-enhanced ultrasound features of hepatocellular carcinoma not detected during the screening procedure..Z Gastroenterol2017;55:748-53

[23] Xie DY,Zhou J,Gao Q.Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma..Hepatobiliary Surg Nutr2017;6:387-96 PMCID:PMC5756765

[24] Kudo M,Izumi N,Kadoya M.JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan..Liver Cancer2014;3:458-68 PMCID:PMC4531423

[25] Vilana R,Bianchi L,Rimola J.Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound..Hepatology2010;51:2020-9

[26] Wildner D,Greis C,Neurath MF.CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial..Ultraschall Med2015;36:132-9

[27] de Sio I,Vitale LM,Del Prete A.Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study..United European Gastroenterol J2014;2:279-87 PMCID:PMC4114116

[28] Giorgio A,Giorgio V.CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started?.Ultraschall Med2011;32:315-6

[29] Giorgio A,Giorgio V.Misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast-enhanced ultrasound: a real new clinical entity or just an exaggerated fear?.Liver Int2013;33:1608

[30] Giorgio A.Diagnostic algorithm of hepatocellular carcinoma on cirrhosis: CEUS or no CEUS, that is the problem..Dig Liver Dis2011;43:499

[31] Jang HJ,Burns PN.CEUS: an essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.Eur J Radiol2015;84:1623-35

[32] Kono Y,Cosgrove D,Jang HJ.Contrast enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS(R)): the official version by the american college of radiology (ACR)..Ultraschall Med2017;38:85-6

[33] Piscaglia F,Lyshchik A,Dietrich CF.American college of radiology contrast enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay..Ultraschall Med2017;38:320-4

[34] Tae Kyoung Kim,Stephanie R Wilson,Fabio Piscaglia.Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system..Clin Mol Hepatol2017;23:280-9 PMCID:PMC5760002

[35] Dietrich CF,Helmberger T,Willmann JK.Contrast-enhanced ultrasound: liver imaging reporting and data system (CEUS LI-RADS)]..Z Gastroenterol2018;56:499-506(in German)

[36] Terzi E,Pompili M,Cabibbo G.Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules; CEUS LI-RADS Italy study group collaborators..J Hepatol2018;68:485-92

[37] Yang D,Tang CL,Guo DY.Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition..Sci Rep2018;8:4713 PMCID:PMC5856788

[38] Schellhaas B,Strobel D,Kielisch C.Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS..Eur Radiol2018;28:4254-64

[39] Schellhaas B,Kielisch C,Neurath MF.Interobserver agreement for contrast-enhanced ultrasound (CEUS)-based standardized algorithms for the diagnosis of hepatocellular carcinoma in high-risk patients..Ultraschall Med2018;39:667-74

[40] Giorgio A,Gatti P,Matteucci P.Contrast-enhanced ultrasound: a simple and effective tool in defining a rapid diagnostic work-up for small nodules detected in cirrhotic patients during surveillance..J Gastrointestin Liver Dis2016;25:205-11

[41] Ling W,Ma X,Li J.The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm)..J Cancer2018;9:2946-52 PMCID:PMC6096371

[42] Giorgio A,di Sarno A,de Stefano G.Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound..Anticancer Res2011;31:3977-82

[43] Aubé C,Lonjon J,Seror O.EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice..Liver Int2017;37:1515-25

[44] Moudgil S,Prabhakar N,Behera A.Comparison of contrast enhanced ultrasound with contrast enhanced computed tomography for the diagnosis of hepatocellular carcinoma..J Clin Exp Hepatol2017;7:222-9 PMCID:PMC5620356

[45] Huf S,Wiesinger I,Scherer MN.Analysis of liver tumors using preoperative and intraoperative contrast-enhanced ultrasound (CEUS/IOCEUS) by radiologists in comparison to magnetic resonance imaging and histopathology..Rofo2017;189:431-40

[46] Seitz K.A milestone: approval of CEUS for diagnostic liver imaging in adults and children in the USA..Ultraschall Med2016;37:229-32